sofidexFor patientsAre you a clinician? Clinical site
Ask Sofi
Listen
Patient SupportEmergencies & Reporting
Log inSign up

Meds & supplements  ›  Aclidinium

Medicine

Aclidinium

DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Do not take if
  • Severe hypersensitivity to milk proteins.
  • Hypersensitivity to aclidinium bromide, formoterol fumarate, or to any component of the product.

What it is used for

Limitations of Use: DUAKLIR PRESSAIR is not indicated for the relief of acute bronchospasm or for the treatment of asthma.

Side effects, and when to stop

LABAs, such as formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, increase the risk of asthma-related death. DUAKLIR PRESSAIR is not indicated for the treatment of asthma.

The following adverse reactions are described in greater detail elsewhere in the labeling:

  • Paradoxical bronchospasm
  • Immediate hypersensitivity reactions
  • Cardiovascular effects
  • Worsening of narrow-angle glaucoma
  • Worsening of urinary retention

Who should not take it

Use of a long-acting beta 2 -adrenergic agonist (LABA), including formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, without an inhaled corticosteroid is contraindicated in patients with asthma. DUAKLIR PRESSAIR is not indicated for the treatment of asthma.

DUAKLIR PRESSAIR is contraindicated in patients with:

  • Severe hypersensitivity to milk proteins.
  • Hypersensitivity to aclidinium bromide, formoterol fumarate, or to any component of the product.

Other medicines and interactions

No formal drug interaction studies have been performed with DUAKLIR PRESSAIR.

2 dosage and administration

The recommended dose of DUAKLIR PRESSAIR is one oral inhalation of 400 mcg/12 mcg, twice daily (once in the morning and once in the evening). Do not take more than one inhalation twice daily.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Aclidinium; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/aclidinium

APA 7th

sofidex. (2026, August 2). Aclidinium. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/aclidinium

AMA 11th

Aclidinium. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/aclidinium

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.